Novare Surgery has raised $16 million in a fourth round of funding to bring its RealHand instruments for “minimally invasive surgery” to market.

The Cupertino start-up said Point Judith Capital and Tudor Investment Corp. led the round of financing and were joined by existing investors Thomas J. Fogarty, Channel Medical Partners, Canaan Partners, Asset Management and new investor Deerfield Partners.

Gina Raimondo, a partner at Point Judith Capital, has been elected to Novare Surgical Systems’ board of directors, bringing board membership to six, the company said.

The RealHand instruments focused on general laparoscopic procedures such as gastric bypass and colectomy.